Publications

  1. Leis AA, Ross MA, Verheijde JL, Leis JF. Immunoablation and Stem Cell Transplantation in Amyotrophic Lateral Sclerosis: The Ultimate Test for the Autoimmune Pathogenesis Hypothesis. Front Neurol 2016; 7:12 Epub 2016 Feb 11
    View PubMed
  2. Gupta HV, Gervais C, Ross MA, Mehta SH. Purkinje Cell Cytoplasmic Antibody (PCA-2)-related Chorea-Dystonia Syndrome. Tremor Other Hyperkinet Mov (N Y) 2016; 6:420 Epub 2016 Sept 24
    View PubMed
  3. Miller RG Block G Katz JS Barohn RJ Gopalakrishnan V Cudkowicz M Zhang JR McGrath MS Ludington E Appel SH Azhir A, Phase 2 Trial NP001 Investigators. Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS. Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9; 2(3):e100.
  4. Leis AA, Szatmary G, Ross MA, Stokic DS. West nile virus infection and myasthenia gravis. Muscle Nerve 2014 Jan; 49 (1):26-9 Epub 2013 Sept 11
    View PubMed
  5. Zhang W, Johnston JA, Ross MA, Sanniec K, Gleason EA, Dueck AC, Santello M. Effects of carpal tunnel syndrome on dexterous manipulation are grip type-dependent. PLoS One. 2013; 8(1):e53751. Epub 2013 Jan 10.
    View PubMed
  6. Ross MA. Electrodiagnosis of peripheral neuropathy. Neurol Clin. 2012 May; 30(2):529-49. Epub 2012 Jan 17.
    View PubMed
  7. Zhang W, Johnston JA, Ross MA, Coakley BJ, Gleason EA, Dueck AC, Santello M. Effects of carpal tunnel syndrome on adaptation of multi-digit forces to object mass distribution for whole-hand manipulation. J Neuroeng Rehabil. 2012; 9:83. Epub 2012 Nov 21.
    View PubMed
  8. Miller RG, Moore DH, Forshew DA, Katz JS, Barohn RJ, Valan M, Bromberg MB, Goslin KL, Graves MC, McCluskey LF, McVey AL, Mozaffar T, Florence JM, Pestronk A, Ross M, Simpson EP, Appel SH, WALS Study Group. Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology. 2011 Sep 6; 77(10):973-9. Epub 2011 Aug 03.
    View PubMed
  9. Zhang W, Johnston JA, Ross MA, Smith AA, Coakley BJ, Gleason EA, Dueck AC, Santello M. Effects of carpal tunnel syndrome on adaptation of multi-digit forces to object weight for whole-hand manipulation. PLoS One. 2011; 6(11):e27715. Epub 2011 Nov 16.
    View PubMed
  10. Hlubocky A, Wellik K, Ross MA, Smith BE, Hoffman-Snyder C, Demaerschalk BM, Wingerchuk DM. Skin biopsy for diagnosis of small fiber neuropathy: a critically appraised topic. Neurologist. 2010 Jan; 16(1):61-3.
    View PubMed
  11. Aksoy IA, Schrader SL, Ali MS, Borovansky JA, Ross MA. Spinal accessory neuropathy associated with deep tissue massage: a case report. Arch Phys Med Rehabil. 2009 Nov; 90(11):1969-72.
    View PubMed
  12. Goodman BP, Bosch EP, Ross MA, Hoffman-Snyder C, Dodick DD, Smith BE. Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy. J Neurol Neurosurg Psychiatry. 2009 May; 80(5):524-7. Epub 2008 May 21.
    View PubMed
  13. Goodman BP, Smith BE, Ross MA. Electromyographic findings in central nervous system disorders: case series and literature review. J Clin Neurophysiol. 2008 Aug; 25(4):222-4.
    View PubMed
  14. Orrell RW, Lane RJ, Ross M. A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler. 2008 Aug; 9(4):195-211.
    View PubMed
  15. Brenner RP, Drislane FW, Ebersole JS, Grigg-Damberger M, Hallett M, Herman ST, Hirsch LJ, Husain AM, Kaplan P, Legatt AD, Nordli DR, Parry GJ, Ross MA, Schomer DL, So EL, Sumner AJ, Tatum WO. Guideline twelve: Guidelines for long-term monitoring for epilepsy. J Clin Neurophysiol. 2008 Jun; 25(3):170-80.
    View PubMed
  16. Ross MA. Intravenous immunoglobulin therapy for neuromuscular disorders. Semin Neurol. 2007 Sep; 27(4):340-6.
    View PubMed
  17. Orrell RW, Lane JM, Ross MA. Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2007 Jan; 24(1):CD 002829.
  18. Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol. 2006 Aug; 63(8):1075-9. Epub 2006 Jun 12.
    View PubMed
  19. Leong SP, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoekstra HJ, Garberoglio C, White RL Jr, Chu D, Biel M, Charney K, Wanebo H, Avisar E, Vetto J, Soong SJ, Sentinel Lymph Node Working Group. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg. 2006 Apr; 132(4):370-3.
    View PubMed
  20. Orrell RW, Lane JM, Ross MA. Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2005 Jan; 25(1):CD 002829.
  21. Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, MacDonald D, et al. A clinical trial of creatine in ALS. Neurology. 2004 Nov 9; 63(9):1656-61.
    View PubMed
  22. Orrell RW, Lane JM, Ross MA. Antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2004 Oct 18; 4:CD002829.
    View PubMed
  23. Olsen AL, Ross M, Stansfield RB, Kreiter C. Pelvic floor nerve conduction studies: establishing clinically relevant normative data. American Journal of Obstetrics & Gynecology. 2003 Oct; 189(4):1114-9.
    View PubMed
  24. Bryan WW, Hoagland RJ, Murphy J, Armon C, Barohn RJ, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA, Stromatt SC, rhCNTF ALS Study Group. Can we eliminate placebo in ALS clinical trials? Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr; 4(1):11-5.
    View PubMed
  25. Plahuta JM, McCulloch BJ, Kasarskis EJ, Ross MA, Walter RA, McDonald ER. Amyotrophic lateral sclerosis and hopelessness: psychosocial factors. Soc Sci Med. 2002 Dec; 55(12):2131-40.
    View PubMed
  26. Flanagan SW, Anderson RD, Ross MA, Oberley LW. Overexpression of manganese superoxide dismutase attenuates neuronal death in human cells expressing mutant (G37R) Cu/Zn-superoxide dismutase. J Neurochem. 2002 Apr; 81(1):170-7.
    View PubMed
  27. Ross MA. Caregiver assessment: con. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002; 3 Suppl 1:S29.
    View PubMed
  28. Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, Miller RG, ALS CARE Study Group. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology. 2001 Aug 14; 57(3):500-4.
    View PubMed
  29. Miller RG, Moore DH 2nd, Gelinas DF, Dronsky V, Mendoza M, Barohn RJ, Bryan W, Ravits J, Yuen E, Neville H, Ringel S, Bromberg M, Petajan J, Amato AA, Jackson C, Johnson W, Mandler R, Bosch P, Smith B, Smith B, Graves M, Ross M, Sorenson EJ, Kelkar P, Parry G, Olney R, Western ALS Study Group. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001 Apr 10; 56 (7):843-8
    View PubMed
  30. Kelkar P, Ross MA, Yamada T. Isolated posterior column dysfunction: an unusual presentation of spondylotic myelopathy.[erratum appears in J Spinal Disord 2001 Feb;14(1):following table of contents]. J Spinal Disord. 2000 Aug; 13(4):356-9.
    View PubMed
  31. Glenn SA, Ross MA. Delayed radiation-induced bulbar palsy mimicking ALS. Muscle & Nerve. 2000 May; 23(5):814-7.
    View PubMed
  32. Kasarskis EJ, Shefner JM, Miller R, Smith RA, Licht J, Mitsumoto H, Hopkins LC, Rosenfeld J, Pascuzzi R, Cornblath DR, Armon C, Strong MJ, Kula R, Windebank A, Bosch EP, Smith BE, Cashman N, Sivak M, Sergay S, Siddique T, Sufit RL, Johnston W, Brooke MB, Graves MC, Olney RK, Bradley WG, Ross M, et al. A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology. 1999 Apr 22; 52(7):1427-33.
    View PubMed
  33. Katz JS, Houroupian D, Ross MA. Multisystem neuronal involvement and sicca complex: broadening the spectrum of complications. Muscle & Nerve. 1999 Mar; 22(3):404-7.
    View PubMed
  34. Magnusson ML, Pope MH, Hasselquist L, Bolte KM, Ross M, Goel VK, Lee JS, Spratt K, Clark CR, Wilder DG. Cervical electromyographic activity during low-speed rear impact. Eur Spine J. 1999; 8(2):118-25.
    View PubMed
  35. Shields RK, Ruhland JL, Ross MA, Saehler MM, Smith KB, Heffner ML. Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam. Arch Phys Med Rehabil. 1998 Jul; 79(7):855-62.
    View PubMed
  36. Shields RK, Chang YJ, Ross M. Neuromuscular propagation after fatiguing contractions of the paralyzed soleus muscle in humans. Muscle & Nerve. 1998 Jun; 21(6):776-87.
    View PubMed
  37. Ross MA, Miller RG, Berchert L, Parry G, Barohn RJ, Armon C, Bryan WW, Petajan J, Stromatt S, Goodpasture J, McGuire D. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology. 1998 Mar; 50(3):768-72.
    View PubMed
  38. Ajax ET, Ross MA, Rodnitzky RL. The role of electromyography (EMG) in the guidance of botulinum toxin (BTX) injections for the treatment of focal dystonia and spasticity of the limbs. J Neurol Rehabil. 1998; 12(1).
  39. McGuire D, Garrison L, Armon C, Barohn RJ, Bryan WW, Miller R, Parry GJ, Petajan JH, Ross MA. A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group. J Neurol Sci. 1997 Oct; 152(Suppl 1):S18-22.
    View PubMed
  40. Ross MA. Acquired motor neuron disorders. Neurol Clin. 1997 Aug; 15(3):481-500.
    View PubMed
  41. Hoagland RJ, Mendoza M, Armon C, Barohn RJ, Bryan WW, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study Group. Muscle & Nerve. 1997 Jun; 20(6):691-5.
    View PubMed
  42. Miller RG, Moore D, Young LA, Armon C, Barohn RJ, Bromberg MB, Bryan WW, Gelinas DF, Mendoza MC, Neville HE, Parry GJ, Petajan JH, Ravits JM, Ringel SP, Ross MA. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group. Neurology. 1996 Dec; 47(6):1383-8.
    View PubMed
  43. Blair WF, Goetz DD, Ross MA, Steyers CM, Chang P. Carpal tunnel release with and without epineurotomy: a comparative prospective trial. J Hand Surg [Am] 1996 Jul; 21(4):655-61.
    View PubMed
  44. McGuire D, Garrison L, Armon C, Barohn R, Bryan W, Miller R, Parry G, Petajan J, Ross M. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group. Neurology. 1996 May; 46(5):1442-4.
    View PubMed
  45. Ionasescu VV, Kimura J, Searby CC, Smith WL Jr, Ross MA, Ionasescu R. A Dejerine-Sottas neuropathy family with a gene mapped on chromosome 8. Muscle & Nerve. 1996 Mar; 19(3):319-23.
    View PubMed
  46. Kelkar P, Ross MA, Murray J. Mononeuropathy multiplex associated with celiac sprue. Muscle & Nerve. 1996 Feb; 19(2):234-6.
    View PubMed
  47. Miller RG, Petajan JH, Bryan WW, Armon C, Barohn RJ, Goodpasture JC, Hoagland RJ, Parry GJ, Ross MA, Stromatt SC. A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Ann Neurol. 1996 Feb; 39(2):256-60.
    View PubMed
  48. Ross MA. Pitfalls in performing repetitive nerve stimulation. Int Cong Ser. 1996; 1101:679-82.
  49. Ross MA, Kimura J. AAEM case report #2: the carpal tunnel syndrome. Muscle & Nerve. 1995 Jun; 18(6):567-73.
    View PubMed
  50. Kelkar P, Ross MA. Natural history of disease and placebo effect. Perspect Biol Med. 1994 Winter; 37(2):244-6.
    View PubMed
  51. Ross MA. Neuropathies associated with diabetes. Med Clin North Am. 1993 Jan; 77(1):111-24.
    View PubMed
  52. Leis AA, Kofler M, Ross MA. The silent period in pure sensory neuronopathy. Muscle & Nerve. 1992 Dec; 15(12):1345-8.
    View PubMed
  53. Yamada T, Saito T, Matsue Y, Honda Y, Fuchigami T, Fujii M, Ross M. The influence of interfering input from the peroneal nerve on tibial-nerve somatosensory evoked potential. Electroencephalogr Clin Neurophysiol. 1992 Nov-Dec; 84(6):492-8.
    View PubMed
  54. Russell JW, Afifi AK, Ross MA. Predictive value of electromyography in diagnosis and prognosis of the hypotonic infant. J Child Neurol. 1992 Oct; 7(4):387-91.
    View PubMed
  55. Ross MA, Leis AA, Krain L, Mitchell G. Normal conduction in pathways traversing an asymptomatic multiple sclerosis plaque. Electroencephalogr Clin Neurophysiol. 1992 Feb; 85(1):42-5.
    View PubMed
  56. Leis AA, Ross MA, Summers AK. Psychogenic seizures: ictal characteristics and diagnostic pitfalls. Neurology. 1992 Jan; 42(1):95-9.
    View PubMed
  57. Leis AA, Ross MA, Emori T, Matsue Y, Saito T. The silent period produced by electrical stimulation of mixed peripheral nerves. Muscle & Nerve. 1991 Dec; 14(12):1202-8.
    View PubMed
  58. Onishi H, Yamada T, Saito T, Emori T, Fuchigami T, Hasegawa A, Nagaoka T, Ross M. The effect of stimulus rate upon common peroneal, posterior tibial, and sural nerve somatosensory evoked potentials. Neurology. 1991 Dec; 41(12):1972-7.
    View PubMed
  59. Machida M, Yamada T, Ross M, Kimura J, Hitchon P. Effect of spinal cord ischemia on compound muscle action potentials and spinal evoked potentials following spinal cord stimulation in the dog. J Spinal Disord. 1990 Dec; 3(4):345-52.
    View PubMed
  60. Tachlbana Y, Yasuhara A, Ross MA. Tap-induced blink reflex and CNS dysfunction in diabetics with hyperosmolality. Eur Neurol. 1990; 30:145-8.
    View PubMed
  61. Yasuhara A, Yamada T, Seki Y, Emori T, Vachatimanont P, Andoh K, Ando M, Ross M, Kimura J. Presence of two subcomponents in P9 far-field potential following stimulation of the median nerve. Electroencephalogr Clin Neurophysiol. 1990; 77:93-100.
    View PubMed
  62. Ross MA, Biller J, Adams HP Jr, Dunn V. Magnetic resonance imaging in Wallenberg's lateral medullary syndrome. Stroke. 1986 May-Jun; 17(3):542-5.
    View PubMed